253 related articles for article (PubMed ID: 2822841)
1. Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.
Sullivan V; Smith GL
J Gen Virol; 1987 Oct; 68 ( Pt 10)():2587-98. PubMed ID: 2822841
[TBL] [Abstract][Full Text] [Related]
2. The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization.
Sullivan V; Smith GL
J Gen Virol; 1988 Apr; 69 ( Pt 4)():859-67. PubMed ID: 2833569
[TBL] [Abstract][Full Text] [Related]
3. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
[TBL] [Abstract][Full Text] [Related]
4. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
[TBL] [Abstract][Full Text] [Related]
5. A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice.
McLaughlin-Taylor E; Willey DE; Cantin EM; Eberle R; Moss B; Openshaw H
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1731-4. PubMed ID: 2839606
[TBL] [Abstract][Full Text] [Related]
6. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
Martin S; Rouse BT
J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
Martin S; Cantin E; Rouse BT
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
[TBL] [Abstract][Full Text] [Related]
8. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts.
Krishna S; Blacklaws BA; Overton HA; Bishop DH; Nash AA
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1805-14. PubMed ID: 2544667
[TBL] [Abstract][Full Text] [Related]
9. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G.
Parkes DL; Smith CM; Rose JM; Brandis J; Coates SR
J Clin Microbiol; 1991 Apr; 29(4):778-81. PubMed ID: 1653787
[TBL] [Abstract][Full Text] [Related]
10. Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge.
Weir JP; Bennett M; Allen EM; Elkins KL; Martin S; Rouse BT
J Gen Virol; 1989 Oct; 70 ( Pt 10)():2587-94. PubMed ID: 2794972
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.
Cremer KJ; Mackett M; Wohlenberg C; Notkins AL; Moss B
Science; 1985 May; 228(4700):737-40. PubMed ID: 2986288
[TBL] [Abstract][Full Text] [Related]
12. Baculovirus-expressed glycoprotein G of herpes simplex virus type 1 partially protects vaccinated mice against lethal HSV-1 challenge.
Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
Virology; 1992 Sep; 190(1):233-9. PubMed ID: 1529531
[TBL] [Abstract][Full Text] [Related]
13. Expression of HSV-1 and HSV-2 glycoprotein G in insect cells by using a novel baculovirus expression vector.
Sánchez-Martínez D; Pellett PE
Virology; 1991 May; 182(1):229-38. PubMed ID: 1850903
[TBL] [Abstract][Full Text] [Related]
14. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
[TBL] [Abstract][Full Text] [Related]
15. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity.
Allen EM; Weir JP; Martin S; Mercadal C; Rouse BT
Viral Immunol; 1990; 3(3):207-15. PubMed ID: 2175194
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
Aurelian L; Smith CC; Wachsman M; Paoletti E
Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants.
Blacklaws BA; Krishna S; Minson AC; Nash AA
Virology; 1990 Aug; 177(2):727-36. PubMed ID: 2164732
[TBL] [Abstract][Full Text] [Related]
18. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies.
Liljeqvist JA; Trybala E; Svennerholm B; Jeansson S; Sjögren-Jansson E; Bergström T
J Gen Virol; 1998 May; 79 ( Pt 5)():1215-24. PubMed ID: 9603337
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples.
Meshkat Z; Roostaee MH; Soleimanjahi M; Zandi K
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):499-502. PubMed ID: 22696877
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG.
Olofsson S; Lundström M; Marsden H; Jeansson S; Vahlne A
J Gen Virol; 1986 Apr; 67 ( Pt 4)():737-44. PubMed ID: 3007660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
